PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB
Clinical trial NCT05685615 · COMPLETED
Trial details
- NCT number
- NCT05685615
- Sponsor
- BioVersys AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-20
- Primary completion
- 2024-11-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.